Physician

Philip Walton Laird, MD

According to 2025 Medicare claims, Philip Laird, MD (NPI: 1548416399) practices ophthalmology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from Martin, FL. This provider's primary affiliated billing organization is RETINA CARE SPECIALISTS PLLC (NPI: 1912192139; TIN: 20-8005671) and primary practice location at 34996-3304.

Laird's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,534 traditional Medicare patients, billed 85,520 HCPCS/CPT codes, and received $4,640,861 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 461 prescription claims across 159 beneficiaries totaling $21,887 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 34 records totaling $12,126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,542,906 to $4,640,861. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.6M2015 Medicare payment: $1,542,906 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,193,534 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,765,929 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,963,394 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,020,513 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,653,144 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,765,799 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,498,536 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,873,909 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,640,861 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201579610,740$1,542,906
201696213,868$2,193,534
20171,12517,090$2,765,929
20181,16318,207$2,963,394
20191,26220,357$3,020,513
20201,20318,461$3,653,144
20211,35319,225$3,765,799
20221,36720,112$3,498,536
20231,37657,644$3,873,909
20241,53485,520$4,640,861

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$40K2015 Drug cost: $27,131 (USD; Tot_Drug_Cst)2016 Drug cost: $26,312 (USD; Tot_Drug_Cst)2017 Drug cost: $29,908 (USD; Tot_Drug_Cst)2018 Drug cost: $40,110 (USD; Tot_Drug_Cst)2019 Drug cost: $33,712 (USD; Tot_Drug_Cst)2020 Drug cost: $29,474 (USD; Tot_Drug_Cst)2021 Drug cost: $31,216 (USD; Tot_Drug_Cst)2022 Drug cost: $33,965 (USD; Tot_Drug_Cst)2023 Drug cost: $31,462 (USD; Tot_Drug_Cst)2024 Drug cost: $21,887 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201591425$27,131
2016113453$26,312
2017113463$29,908
2018143575$40,110
2019121406$33,712
2020108392$29,474
2021142405$31,216
2022141508$33,965
2023130432$31,462
2024159461$21,887

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5992,360$98
92014Established patient complete exam of visual system1,1741,656$93
92012Established patient problem focused exam of visual system6091,182$68
92134Imaging of retina1,4273,549$31
92250Photography of the retina733975$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium22666$7,672
Prednisolone AcetatePrednisolone Acetate1356,342$5,699
Ketorolac TromethamineKetorolac Tromethamine461,790$979
MoxifloxacinMoxifloxacin Hcl48820$875
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat221,920$397

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$981Dutch Ophthalmic, USA
Research PaymentsReported research-related payment or transfer-of-value amount.11$11,144Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.1$14,616US Retina LLC

FAQ

What Medicare data is available for Philip Walton Laird, MD?

Tedicare shows public-source Medicare data for Philip Walton Laird, MD (NPI 1548416399), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip Walton Laird, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Philip Walton Laird, MD?

Philip Walton Laird, MD is linked to RETINA CARE SPECIALISTS PLLC (billing NPI 1912192139) in the available physician profile data.

Does Philip Walton Laird, MD have Open Payments data?

Philip Walton Laird, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.